Anticancer property and normal cell toxicity profile of pyrrolidine‐based platinum (II) complexes: Their DNA, BSA interaction, and molecular docking
- 25 August 2022
- journal article
- research article
- Published by Wiley in Applied Organometallic Chemistry
- Vol. 36 (11)
Abstract
The bioactivity and cytotoxic property of cis‐[Pt (AEP)Cl2] (C‐1); [Pt (AEP)(OH2)2](NO3)2 (C‐2); [Pt (AEP)(GSH) (C‐3)]; and [Pt (AEP)(DL‐meth)]2+(C‐4) (where AEP = 1‐[2‐Aminoethyl] pyrrolidine; GSH = Glutathione; DL‐meth = DL‐methionine) were extensively investigated to find out the more active and less toxic anticancer lead molecules. Spectroscopically characterized Pt (II) complexes (C‐1 to C‐4) were under investigation for their anticancer activity and bio‐molecular interaction with DNA and BSA. The binding property of the complexes toward DNA and BSA were evaluated by UV–Vis, fluorescence spectroscopy, gel electrophoresis, cyclic voltammetry (CV), circular dichroism (CD), and viscometric methods for their pharmacokinetic and pharmacodynamics importance. The BSA binding activity as well as their “Drug reservoir” property of Pt (II) complexes were highlighted for their biological significance. Furthermore, to assess the manner of interaction and also binding strength of the complexes with DNA and BSA molecule, a theoretical approach by molecular docking was performed, utilizing the optimized structure of the complexes. Structural optimization has been performed with density functional theory (DFT) correlation functional (B3LYP) at 6‐31G + (d, p) and LANL2DZ basis set was used for C, N, H, O, S, and metal, respectively. In vitro anticancer activity and level of ROS generation in presence of each complex were explored on A549 cancer cell as well as normal human cell lines HEK293, and their potential cytotoxic property was observed as compared to well‐known recognized anticancer cisplatin.Keywords
Funding Information
- Human Resource Development Group (01(2946)/18/EMR‐II)
This publication has 69 references indexed in Scilit:
- Nickel(II)-Schiff base complex recognizing domain II of bovine and human serum albumin: Spectroscopic and docking studiesSpectrochimica Acta Part A: Molecular and Biomolecular Spectroscopy, 2012
- Ruthenium–Arene Complexes of Curcumin: X-Ray and Density Functional Theory Structure, Synthesis, and Spectroscopic Characterization, in Vitro Antitumor Activity, and DNA Docking Studies of (p-Cymene)Ru(curcuminato)chloroJournal of Medicinal Chemistry, 2012
- Novel palladium(II) complexes containing a sulfur ligand: structure and biological activity on HeLa cellsJBIC Journal of Biological Inorganic Chemistry, 2011
- Oxidative and Nitrosative Stress in the Metastatic MicroenvironmentCancers, 2010
- Crystal structures, antioxidation and DNA binding properties of Dy(III) complexes with Schiff-base ligands derived from 8-hydroxyquinoline-2-carboxaldehyde and four aroylhydrazinesEuropean Journal of Medicinal Chemistry, 2009
- Platinum Anticancer Coordination Compounds: Study of DNA Binding Inspires New Drug Design (Eur. J. Inorg. Chem. 10/2009)European Journal of Inorganic Chemistry, 2009
- Towards Antitumor Active trans‐Platinum CompoundsEuropean Journal of Inorganic Chemistry, 2009
- Molecular mechanisms of resistance and toxicity associated with platinating agentsCancer Treatment Reviews, 2007
- A Quantitative Nitroblue Tetrazolium Assay for Determining Intracellular Superoxide Anion Production in Phagocytic CellsJournal of Immunoassay and Immunochemistry, 2006
- Molecular polarization potential maps of the nucleic acid basesInternational Journal of Quantum Chemistry, 1996